Economic Times | Applications Open for the Asian Fund for Cancer Research’s BRACE Award Venture Competition

Economic Times | Applications Open for the Asian Fund for Cancer Research’s BRACE Award Venture Competition

Economic Times | Applications Open for the Asian Fund for Cancer Research’s BRACE Award Venture Competition 1200 800 Hugill & Ip
Reading Time: 2 minutes

First of Its Kind Investment Opportunity for Asia-Based Oncology Technology Start-Ups

HONG KONG, 4 August 2020 – The Asian Fund for Cancer Research (AFCR) is now accepting applications from oncology start-ups for the Bridging Research from Academia to Cancer Entrepreneurship (BRACE) Award Venture Competition. The event and program uniquely supports Asian entrepreneurs’ cancer technology commercialization and start-up business efforts.

The BRACE Award Venture Competition offers financial and other support to oncology companies which most biopharmaceutical corporations and investors deem as at too early a stage, including those recently spun-out of cancer research laboratories. The program avails participants to potential investment and cash awards, key opinion leaders, insightful feedback from life sciences industry figures, increased visibility and credibility, and opportunity to further tap into AFCR’s extensive global network.

Accepted BRACE Award Venture Competition applications will be reviewed by a selection committee comprised of leading cancer researchers and industry executives, investors and entrepreneurs. Additionally, all accepted applications will have the opportunity to showcase their companies and technologies in a short video to be voted on by the public as the “People’s Choice.” Top applicants as determined by the selection committee, along with the winning applicant of the online voting, will advance as semi-finalists.

The semi-finalists will deliver virtual private and confidential presentations to a world-class judging committee, and two finalists will be selected and granted cash prizes of HK$10,000. Among the finalists, professional due diligence will be performed in determining the BRACE Award Venture Competition winner, which will receive up to HK$2,000,000 in equity investment from AFCR and be announced and featured at the BIOHK2021 international convention— scheduled for 10-13 March 2021 in Hong Kong.

With the BRACE Award Venture Competition and infusion of investment into its winner, AFCR aims to raise awareness of the importance of accelerating commercialization of cancer research innovations that could save patients’ lives” says Asian Fund for Cancer Research Chief Executive Officer Sujuan Ba, Ph.D. “We also hope to build up critically needed ecosystems helping life sciences entrepreneurs throughout the Asia-Pacific region.

The BRACE Award Venture Competition is an important addition to our region’s cancer technology and biomedical industry environment, fostering ideas and approaches on the cutting edge of research” expressed AFCR Chairman of the Board Gary Wong, a partner of Hugill & Ip Solicitors, which is one of the event sponsors. “Few sources are willing to invest in high risk, pre-clinical start-ups and, through the BRACE program, our organization is proud to be in the lead.

Learn more about the BRACE Award Venture Competition and apply before 31 August at

Originally published on Economic Times – both on the English and Chinese versions of the website

Privacy Preferences

When you visit our website, it may store information through your browser from specific services, usually in the form of cookies. Here you can change your Privacy preferences. It is worth noting that blocking some types of cookies may impact your experience on our website and the services we are able to offer.

For performance and security reasons we use Cloudflare
Google Analytics tracking code disabled/enabled
Google Fonts disabled/enabled
Google Maps disabled/enabled
video embeds (e.g. YouTube) disabled/enabled
View our Privacy Policy
We don't eat shark fin but our website does use cookies, mainly for analytics and provision of content from other websites. Define your Privacy Preferences and agree to our use of cookies. Privacy Policy